Tokyo, Sept. 3 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062789) titled 'A retrospective observational study on the efficacy and safety of elobixibat in patients with schizophrenia and chronic constipation.' on Sept. 2.
Study Type:
Observational
Primary Sponsor:
Institute - Fujita Kokoro Care Center, Okehazama Hospital
Condition:
Condition - Schizophrenia and Chronic Constipation
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The objective of this study is to investigate the efficacy and safety of elobixibat in patients with schizophrenia who have chronic constipation. In addition, the relationship between bowel movement frequency and...